UCSF 42nd Annual Advances in Heart Disease 2025

42nd Annual Advances in Heart Disease December 12 – 14, 2025 Mission Bay Conference Center • San Francisco, CA
Our 42nd annual course will again strive to present topics that highlight new evidence-based medicine findings reported within the last one to two years that impact clinical practice. These will range across a variety of cardiologic subspecialty interests including heart failure, arrhythmias, cardiac surgery, gene therapy, aortic diseases, prevention and artificial intelligence.
Our faculty will include a distinguished group of visiting academicians from North America together with outstanding teachers and clinicians from the University of California, San Francisco.
TARGET AUDIENCE 
This course is intended for cardiovascular specialists, practicing cardiologists, internists, family physicians, cardiovascular and critical care nurses, and physician assistants.
Objectives
An attendee completing this course will be able to improve skills and strategies to:

Provide the best management of coronary heart disease, hypertension, lipid disorders, diabetes, systolic and diastolic heart failure, atrial fibrillation, STEMI and non-STEMI, thromboembolic disease;
Refine considerations for atrial fibrillation, atrial flutter, and ventricular tachycardia ablation;
Apply the best considerations of percutaneous interventions for coronary heart disease;
Improve the use of anti-platelet and anti-coagulation therapy for cardiovascular diseases;
Recognize risk stratification of cardiovascular disease;
Apply the best consideration of percutaneous treatment of valvular heart disease;
Recognize that pathophysiology of diseases and treatment options are impacted by social determinants of health and implement strategies to improve health outcomes among all patients.

 
+ Topics:

Date/Time
Topic/Title
Speaker(s)

Friday, 
Dec 12, 2025

7:50 AM
Course Webinar Opens

8:00
Welcome and Symposium Overview
Peter Ganz, MD, FACC

Session: Frontiers in Interventional Cardiology
Chair: Lucas Zier, MD, MS

8:05
Proactive Management of Severe Aortic Stenosis: From Detection to Early Treatment
Sammy Elmariah, MD, MPH, FACC

8:45
Updates on the Management of Mitral and Tricuspid Valve Disease
Michela Faggioni, MD, FACC

9:25
A New Perspective on Old Therapies for Myocardial Infarction: Beta Blockers and Spironolactone
Krishan Soni, MD, MBA, FACC

10:05
Coffee Break

10:20
Review of Treatment Guidelines for ACS
John MacGregor, MD, PhD, FACC

11:00
Renal Denervation Therapy for Resistant Hypertension
Joseph Yang, MD, FACC

11:40
Updates on Chronic Total Occlusions and Complete Revascularization
Yousif Ahmad, MBBS, PhD

12:20 PM
Lunch (Optional Product Theater)

Session: Advances in Cardiovascular Disease Management and Prevention
Chair: Peter Ganz, MD

1:50 PM
Cardiovascular-kidney-metabolic (CKM) Syndrome
Chiadi E. Ndumele, MD, PhD

2:30
Elliot Rapaport, MD Keynote Lecture: Pulmonary Embolism- Historical Perspective and Glimpses into the Future
Samuel Z. Goldhaber, MD

3:15
Update on the Management of Hypertension – 2025 AHA/ACC Guidelines
Mary Gray, MD

3:55
Coffee Break

4:10
Update on Cardiovascular Complications of Cancer Treatments
Javid Moslehi, MD

4:50
Contemporary Pulmonary Hypertension Management
Marc Simon, MD, MS, FACC

5:30
Adjourn

Saturday, 
Dec 13, 2025

7:30 AM
Continental Breakfast

7:50
Course Webinar Opens

8:00
Announcements
Peter Ganz, MD

Session: Advances and Controversies in Electrophysiology
Chair: Nora Goldschlager, MD, FACC

8:05
Leadless vs. Leaded Pacemakers – Which One for Which Patient?
Adam Oesterle, MD

8:45
When to Anticoagulate Device-detected Atrial Fibrillation – Latest Evidence
Joshua Moss, MD, MS, FACC

9:25
PACs and Atrial Fibrillation – Association or Causation
Edward Gerstenfeld, MD, MS, FACC

10:05
Coffee Break

10:20
Which ICD is Best for my Patient: Transvenous, Subcutaneous (S-ICD), or Extravascular (EV-ICD)?
Daniel Morin, MD, MPH

11:00
Atrial Fibrillation and Stroke Prevention – Current Evidence and Glimpse into the Future
Cara Pellegrini, MD

11:40
Lifestyle and Atrial Fibrillation: Conventional Wisdom versus the Evidence
Gregory Marcus, MD, MAS, FACC

12:20 PM
Lunch (Optional Product Theater)

Session: Advances and Controversies in Electrophysiology (cont.) Chair: Nora Goldschlager, MD, FACC

1:20 PM
How to Evaluate Family Members of SCA Victims?
Albert Liu, MD

Session: Advances in Heart Failure
Chair: Jonathan Davis, MD, MPH

1:50
The Expanding Role of SGLT2 inhibitors and GLP1-Receptor Agonists in Heart Failure and Beyond
Carlos Santos-Gallego, MD

2:30
A Contemporary Approach to Identifying, Classifying, and Treating Cardiogenic Shock
Christopher Barnett, MD, MHP, FACC

3:10
Coffee Break

3:25
What’s Coming Down the Pipe for Heart Failure.
Liviu Klein, MD, MS

4:05
Finerenone vs. Spironolactone: Where Does the Non-steroidal MRA Fit into Contemporary Practice?
Shweta Motiwala, MD, MPH, FACC

4:45 PM
Adjourn

Sunday, 
Dec 14, 2025

7:30 AM
Continental Breakfast

8:00
Announcements
Peter Ganz, MD

Session: Advances in Managing Cardiovascular Diseases
Chair: Mary Gray, MD

8:05
Updates in Pericarditis: From Pathophysiology to Practice
Alan Baik, MD, PhD

8:45
Management of Cardiovascular Disease for Patients with Kidney Failure Undergoing Maintenance Dialysis
Ruth Dubin, MD

9:25
Managing Cardiovascular Disease in Pregnancy
Aarthi Sabanayagam, MD, MBBS, FACC

10:05
Iron Deficiency: A Low Hanging Mineral in Heart Failure Management
Pooja Prasad, MD

10:45
Use of Artificial Intelligence and Machine Learning to Improve Cardiovascular Outcomes
Lucas Zier, MD, MS

11:25
Inflammation in the Detection and Treatment of Atherosclerotic Disease
Paul M. Ridker, MD, MPH

12:05 PM
Adjourn